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Background: Most studies that follow up hepatectomy cases are limited in scope to an investigation of mortality
and morbidity rates or the costs and length of hospital stay. In this study the authors aimed to characterize the
quality of life and to evaluate mortality and its determinants after hepatectomy.
Methods: This prospective study was carried in a Post-Anaesthesia Care Unit (PACU) over 15 months, and 70
patients submitted to hepatectomy were enrolled. Demographic and peri-operative characteristics were evaluated
for associations with mortality. At admission and 6 months after discharge, patients completed a Short Form-36
questionnaire (SF-36) and have their independence in Activities of Daily Living (ADL) was evaluated. Binary and
multiple logistic regression analyses were used to evaluate of associations with mortality, and the Wilcoxon signed
rank test was used to compare SF-36 scores before and after 6 months after hepatectomy.
Results: The mortality rate was 19% at 6 months. Multivariate analysis identified postoperative delirium as an
independent determinant for mortality. Six months after discharge, 46% patients stated that their health in general
was better or much better than that 1 year previously. Six months after hepatectomy, patients had worse scores in
the physical function domain of SF-36; however, scores for all the other domains did not differ. At this time point,
patients were more dependent in instrumental ADL than before surgery (32% versus 7%, p = 0.027).
Conclusion: This study identified postoperative delirium as an independent risk factor for mortality 6 months after
hepatectomy. After 6 months, survivors were more dependent in instrumental ADL tasks and had worse scores in
the physical function domain of SF-36.
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Although some studies have documented the beneficial
outcome after hepatectomy surgery, most have been
limited in scope to mortality and morbidity rates, or cost
and length of hospital stay (LOS) [1,2]. Few studies have
examined the dependence of these patients, and how
they perceive changes in their own health after this pro-
cedure. In addition, little is known about the extent and
impact of these changes on patient outcome.
Health-related quality of life (HRQOL) is recognized
as an important component in the outcome evaluation
of survivors and is also an indicator of patients’ general
health status [3]. It has even been suggested that studies* Correspondence: abelha@mail.telepac.pt
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reproduction in any medium, provided the oron outcome after Intensive Care Unit (ICU) stay should
include HRQOL measurements [4].
Several questionnaires have been validated for the
study of HRQL [5-9], and most of the measures that
have been used are multi-item scales. Some multiple-
item scales provide a total score as well as generating
subscales that provide information on particular aspects.
The Short-Form General Health Survey (SF-36) was
developed during the Medical Outcomes Study (MOS)
to measure generic health concepts that are relevant
across age, disease and treatment groups [10]. It is a
valid, self-completed questionnaire covering all aspects
of Health Related Quality of Life (HRQOL); the Sf-36
has been used for post discharge ICU patients and for
studying groups with other diseases; in addiction, it
shows excellent reliability and validity [10,11]. Thistd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Portuguese and validated in a study by Ferreira [12,13].
Low functional status is associated with higher surgical
risk. Patients who have only minor or non-clinical pre-
dictors of surgical risk, but with poor functional capacity
are recommended to undergo noninvasive testing prior
to hepatectomy. The determination of functional out-
come and the identification of predictors of survival and
functional recovery after hepatectomy may be funda-
mental in terms of evaluating the risk for these patients
and for promoting proper treatment. The ability to care
for oneself and live independently is considered a mea-
sure of functional outcome after hospitalization [14].
Functional status refers to the level of involvement in ac-
tivities and is often used as a synonym for performance
in Activities of Daily Living (ADL) [15]. ADL appraisal
scales consider functional and instrumental activities.
Patients’ ability to handle such activities has been assessed
by generic or disease-specific measures of physical func-
tional status. Furthermore, Katz’s Activities of Daily Living
Scale [15] and the Lawton Instrumental Activities of Daily
Living [16] have been used to investigate critical care
survivors.
The aim of the present study was to characterize the
quality of life and to evaluate mortality and its determi-
nants after hepatectomy.
Methods
The Institutional Review Board of the Centro Hospitalar
São João approved the study protocol, and written con-
sent was obtained from all patients.
This prospective cohort study was carried out in the
multidisciplinary Post-Anaesthesia Care Unit (PACU) at
the 1124-bed Centro Hospitalar São João, a community
teaching hospital in Porto, Portugal, over a period of 15
months, beginning in March 2009. The PACU has a 5-
bed Surgical ICU.
All consecutive postoperative patients submitted to
elective hepatectomy and who were admitted to the sur-
gical ICU area of the PACU were enrolled in the study.
Patients readmitted during the study period were en-
rolled in relation to the time of their first admission.
The following clinical variables were recorded on ad-
mission to the ICU: age, sex, body weight, height and
the American Society of Anesthesiologists physical status
(ASA-PS). At admission, the core temperature was also
registered. The ICU and in-hospital LOS and mortality
were also recorded for all patients, and the Score of Sim-
plified Acute Physiology Score (SAPS) II [17] and Acute
Physiology & Chronic Health Evaluation (APACHE) II
[18] were calculated using standard methods.
Specifically, pre admission comorbidities and any history
of ischaemic heart disease, congestive heart disease, cere-
brovascular disease, hypertension, renal insufficiency,diabetes, or hyperlipidaemia were recorded. The presence
of coexisting conditions was assessed using the secondary
diagnoses of the International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM). Adap-
ting a classification scheme developed by Lee et al. [19],
we calculated a Revised Cardiac Risk Index (RCRI) score
for each patient, assigning 1 point for each risk factor.
Each patient admitted was evaluated prospectively for
the diagnosis of delirium, using the Intensive Care Screen-
ing Checklist (ICDSC) [20]; this evaluation was conducted
by research staff physicians and a bedside nurse. The
scores were assigned to each ICU patient by a nurse dur-
ing every shift, and patients were either categorized as not
having delirium” (scores of 0–3) or having delirium (scores
of 4 or higher). ICDSC assessments were carried out at
least once every 8 h for the entire duration of patients’ stay
at the PACU. All the patients yielding an ICDSC score of
4 or higher at least once were considered to have post-
operative delirium.
Medical outcome survey Short-Form 36 (SF-36)
The HRQOL was assessed by the Medical Outcomes
Study Short-form Health Survey (SF-36) [11]. The SF-36
evaluates 8 health domains considered to be important
for patient well-being and health status. These domains
reflect physical health and mental health, and the effects
of health on daily functioning. There is 1 unscaled item
that addresses self-reported changes in the respondent’s
health status during the past year.
The answers to the question in SF-36 about self-reported
changes in health status (“compared to one year ago, how
you would rate your health in general now?”) were classi-
fied in three categories, as better/much better, remained
the same and worse/much worse than 1 year ago.
To minimize distress for the next of kin, each patient’s
records were checked on the hospital information sys-
tem after 6 months to ascertain whether they were still
alive. A copy of a formal letter was sent to all known
survivors accompanied by a return envelope and a vali-
dated Portuguese SF-36 self-report form [12,13]. This
version of the SF-36 has been validated for the study
population in the Porto area from where the subjects of
this study were drawn [21].
At admission and 6 months after PACU discharge,
patients were asked to answer the SF-36 questionnaire
for evaluating their quality of life.
Activities of Daily Living (ADL)
Functional capacity was evaluated before surgery and 6
months after PACU discharge. We used a questionnaire
to evaluate functional capacities of patients according to
their ability to undertake personal ADL (P-ADL) and in-
strumental ADL (I-ADL). This questionnaire was based
on Katz’ Index of Independence in ADL [22] and
Table 1 Patient characteristics and outcome
Variable All Malignant Benign P
(n =70) (n = 58) (n = 12)
Age in years, median (IQR) 59 (48–67) 61 (52–69) 43 (35–52) <0.001c
Age group, n (%) 0.002b
<65 years 42 (60) 30 (52) 12 (100)
65 years 28 (40) 28 (48) 0 (0)
Sex, n (%) 0.011a
Male 35 (50) 33 (57) 2 (17)
Female 35 (50) 25 (43) 10 (83)
ASA physical status, n (%) <0.001a
I/II 23 (33) 11 (19) 12 (100)
III/IV 47 (67) 47 (81) 0 (0)
Body Mass Index in Kg/m2, median (IQR) 25 (22–30) 26 (23–30) 22 (21–30) 0.163b
Type of anesthesia, n (%) 0.440a
General 59 (84) 48 (83) 11 (92)
Combined general locorregional 11 (16) 10 (17) 1(8)
Duration of anesthesia (minutes), median (IQR) 300 (268–360) 300 (270–360) 285 (245–315) 0.298b
Intraoperative fluid volume
Crystalloids (L.), median (P25–P75) 4.0 (3.2 – 4.9) 4.0 (3.3 – 4.9) 3.0 (3.0 – 5.2) 0.174b
Colloids (L.), median (P25–P75) 0.5 (0 – 0.5) 0.5 (0 – 0.5) 0 (0 – 0.4) 0.083b
Erythrocytes (Unit), median (P25–P75) 0 (0 – 1.0) 0 (0 – 1.0) 0 (0 – 0.0) 0.163b
Fresh Frozen plasma (Unit), median (P25–P75) 0 (0–0) 0 (0–0) 0 (0–0) 0.295b
Platelets (Unit), median (P25–P75) 0 (0–0) 0 (0–0) 0 (0–0) 0.517b
Temperature at PACU admission (°C), median (IQR) 34.7 (33.9–35.5) 34.8 (33.9–35.6) 34.7 (33.5–35.2) 0.623b
Hypertension, n (%) 37 (53) 35 (60) 2 (17) 0.006a
Hyperlipidemia, n (%) 25 (36) 24 (41) 1 (8) 0.030a
Pulmonary obstructive disease, n (%) 8 (11) 8 (14) 0 (0) 0.172a
Ischemic heart disease, n (%) 6 (9) 6 (10) 0 (0) 0.244a
Congestive heart disease, n (%) 10 (14) 10 (17) 0 (0) 0.132a
Cerebrovascular disease, n (%) 3 (4) 3 (5) 0 (0) 0.778a
Renal insufficiency, n (%) 4 (6) 3(5) 1 (8) 0.668a
Insulin therapy for diabetes, n (%) 3 (4) 3(5) 0 (0) 0.421a
Total RCRI, n (%) 0.349a
≤2 66 (94) 54 (93) 12 (100)
>2 4 (6) 4 (7) 0 (0)
Katz scale, median (IQR) 0 (0–0) 0 (0–0) 0 (0–0) 0.424b
Dependency in I-ADL, n (%) 3 (4) 3 (5) 0 (0) 0.421a
Lawton I-ADL, median (IQR) 7 (7–7) 7 (7–7) 7 (7–7) 0.176b
Dependency in P-ADL, n (%) 7 (10) 7 (12) 0 (0) 0.205a
SAPS II, median (P25–75) 24 (15–37) 29 (21–39) 7 (0–13) <0.001b
APACHE II, median (IQR) 7 (5–11) 8 (6–11) 4 (3–6) <0.001b
AKI 7 (10) 6 (10) 1(8) 0.833a
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Table 1 Patient characteristics and outcome (Continued)
Delirium 17 (24) 17 (29) 0 (0) 0.025a
PACU length of stay (minutes), median (IQR) 21 (19–57) 21 (19–57) 31 (20–60) 0.501a
Hospital length of stay (days), median (IQR) 10 (7–15) 11 (7–16) 8 (7–11) 0.034b
Mortality in PACU, n (%) 3(4) 3 (5) 0 (0) 0.421a
Mortality in hospital, n (%) 5 (7) 5 (9) 0 (0) 0.291a
Mortality at 6 months follow-up 13 (19) 13 (22) 0 (0) 0.011a
a Fisher’s exact test, b Mann-Whitney U test, IQR, interquartile range.
RCRI, Revised Cardiac Risk Index I-ADL, Instrumental Activities of Daily Living; P-ADL, Personal Activities of Daily Living; SAPS II, Simplified Acute Physiology Score,
APACHE II Acute Physiology & Chronic Health Evaluation PACU, Post Anaesthesia Care Unit; IQR, interquartile range.
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into 2 groups, i.e. able or unable to perform each activity
or group of activities. Patients were classified by their
ability to perform physical and psychosocial ADL, and
the following 4 categories were possible: (a) I-ADL and
P-ADL independent, (b) I-ADL dependent but P-ADL
independent, (c) P-ADL dependent but I-ADL independ-
ent and (d) both P-ADL and I-ADL dependent.
ADL was evaluated by the same investigator who ques-
tioned patients in person before and 6 months after sur-
gery. When it was not possible to question patients directly,
patients were questioned over the telephone.
Outcome
The outcome endpoints considered were: (1) functional
capacity and ADL, i.e. patients were considered dependent
if they were dependent in at least 1 I-ADL or P-ADL acti-
vity; (2) quality of life, i.e. quality of life was evaluated
at admission and 6 months after PACU discharge; and
(3) mortality, i.e. patients were considered survivors if they
were alive 6 months after PACU discharge.
Statistical methods
Descriptive analyses of variables were used to summarize
data and the Mann-Whitney U test was used to compare
continuous variables between 2 groups of subjects. The
chi-square test or Fisher’s exact test were used to com-
pare proportions between 2 groups of subjects.
To identify independent predictors of mortality we
performed univariate analyses using simple binary logistic
regression with an odds ratio (OR) and 95% confidence
interval (CI) with the following independent variables: type
of surgery, age, sex, Body Mass Index (BMI), ASA-PS,
temperature at admission to the PACU, comorbidities,
RCRI score, duration of anaesthesia, and severity of disease
scores (APACHE II and SAPS II). All variables were
deemed to be significant if P < 0.05.
Multiple regression binary logistic was used forcing all
variables in the model in order to identify independent
predictors of mortality at 6 months follow-up. In this
model, all covariates with p < 0.05 in the univariate ana-
lyses were entered; because of high correlation andcolinearity between APACHE II and SAPSII only one of
the severity of disease scores (SAPS II) was entered in this
analysis. Age and length of ICU stay were also entered in
this analysis to adjust for potential confounders.
The related samples Wilcoxon signed rank test was
used to compare SF-36 scores before surgery and 6
months after surgery.
SPSS for Windows version 16.0 (SPSS, Chicago, IL,
USA) was used to analyze the data.Results
During the study period, 70 patients met the inclusion
criteria. The characteristics of all patients enrolled in the
study are given in Table 1.
Fifty per cent were male. The median age was 59 years,
the median SAPS II was 24, median APACHE II was 7
and the median LOS in the PACU was 21 hours. Five
patients (7%) died during their hospital stay (Table 1).
Fifty-eight patients (83%) had surgery because of malig-
nant disease: this comprised primary tumors in 19 patients
(27%) and secondary tumors in 39 patients (56%). Twelve
patients (17%) had surgery because of benign disease.
Patients who submitted to hepatectomy because of malig-
nancy were older, were more likely to be male, had higher
ASA physical status, received higher amounts of erythro-
cytes during surgery, had a higher incidence of hyperten-
sion and hyperlipidaemia, were more severely ill, had more
frequently postoperative delirium, had longer LOS and had
higher mortality at 6 months follow-up (Table 1).
Sixty-five patients were discharged from the hospital;
13 died before the 6 month evaluation (19% global mor-
tality at the time of evaluation). Of the remaining 57
patients, 23% did not answer the questionnaires at the 6
months follow-up but were known to be alive.
The characteristics of survivors and non-survivors at 6
months of follow-up are presented in Table 2. All patients
submitted to surgery because of benign disease have sur-
vived and the mortality rate for patients with a malignant
disease was 22% (Fisher’s exact test, P = 0.066). Of the 57
survivors, 49% were men, and the median age was 57
years. The median SAPS II score for this group was 24,
Table 2 Univariate analysis for determinants of survival after hepatectomy
Variable Nonsurvivors/survivors OR (95% CI) P (a)
n (%) or median (IQR) n = 13 n = 57
Type of hepatectomy surgery 0.105 (b)
for malignant disease 13 (100) / 45 (78) –
for benign disease 0 (0) /12 (21) 1
Age 65 (54 – 71) / 57 (44 – 66) 1.04 (0.99 – 1.10) 0.109
Gender 0.759
Female 6 (46) / 29 (51) 1
Male 7 (54) / 28 (49) 0.83 (0.25 – 2.77)
BMI, median 25 (22 – 31) /25 (22 – 29) 0.99 (0.88 – 1.13) 0.981
Type of anesthesia 0.424
General 10 (77) /49 (86) 1
Combined general loco regional 3 (23) / 8 (14) 1.84 (0.41 – 8.16)
Duration of anesthesia (minutes) 300 (255 – 395) / 300 (265–330) 1.01 (0.99 – 1.01) 0.161
ASA Physical status 0.443 (b)
I/II 0 (0) /23 (40) 1
III/IV 13 (100) / 34 (60) –
Intraoperative fluid volume, median
Crystalloids (L.) 4.2 (4.0– 5.0) / 4.0 (3.1 – 4.9) 1.26 (0.86 – 1.87) 0.239
Colloids (L.) 0.5 (0–1.0) / 0.5 (0 – 0.5) 1.39 (0.34 – 5.79) 0.649
Erythrocytes (Unit) 1 (0 – 3.0) / 0 (0 – 1) 2.92 (1.25 – 6.81) 0.013
Fresh Frozen plasma (Unit) 0 (0 – 0) / 0 (0 – 0) 1.44 (0.80 – 2.58) 0.221
Platelets (Unit) 0 (0 – 0) / 0 (0 – 0) – 1
Temperature at admission 34.2 (33.3 – 35.1) / 35.0 (33.9 – 35.6) 0.72 (0.44 – 1.17) 0.184
Hypertension 8 (62) / 29 (51) 1.55 (0.45 – 5.30) 0.489
Hyperlipidaemia 7 (54) / 18 (32) 2.53 (0.74 – 8.61) 0.138
Pulmonary obstructive disease 2 (15) / 6 (11) 1.55 (0.28 – 8.70) 0.621
Ischemic heart disease 3 (23) / 3 (5) 5.40 (0.95 – 30.7) 0.057
Congestive heart disease 3 (23) / 7 (12) 2.14 (0.47 – 9.73) 0.324
Cerebrovascular disease 2 (15) /1 (2) 10.18 (0.85 – 122) 0.067
Insulin therapy for diabetes 2 (15) / 1 (2) 10.18 (0.85 – 122) 0.067
Renal insufficiency 1 (8) / 3 (5) 1.50 (0.14 – 15.7) 0.735
RCRI 0.019
≤2 10 (77) / 56 (98) 1
>2 3 (23) / 1 (2) 16.8 (1.59 – 178)
Delirium 9 (69) / 8 (14) 13.78 (3.42 – 55.60) <0.001
Previous score in Katz scale 0 (0 – 0) / 0 (0 – 0) – 1
Previous score in Lawton scale 7 (7 – 7) / 7 (7 – 7) – 1
SAPS II, median 32.0 (23.5 – 48.0) / 24.0 (13.0 – 33.5) 1.07 (1.02 – 1.12) 0.011
APACHE II 12.0 (10.5 – 16.0) / 7.0 (4.0 – 9.0) 1.55 (1.21 – 1.98) <0.001
Length of PACU stay (hours) 20 (18 – 80) / 21 (19 – 50) 1.01 (0.99 – 1.03) 0.276
Length of Hospital stay (days) 14 (7 – 17) / 10 (7 – 13) 1.00 (0.95 – 1.06) 0.906
IQR, Interquartil range; OR, Odds Ratio; CI, Confidence Interval.
a) P value (binary logistic regression); b) Fisher’s exact test.
BMI, Body mass index; ASA, American Society of anesthesiologists; RCRI, Revised cardiac risk index; PACU, Post Anesthesia Care Unit; SAPS, Simplified Acute
Physiology Score; APACHE II Acute Physiology & Chronic Health Evaluation.
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Table 3 Multivariate regression analysis for predictors of mortality
Variable Simple OR (95% CI) p Adjusted* OR (95% CI) Pa
Age 1.04 (0.99 – 1.10) 0.109 0.97 (0.89 – 1.05) 0.438
Length of PACU stay (minutes) 1.01 (0.99 – 1.03) 0.276 0.98 (0.95 – 1.01) 0.263
Erythrocytes (Unit) 2.92 (1.25 – 6.81) 0.013 3.06 (0.95 – 9.84) 0.061
RCRI 0.019 0.152
≤2 1 1
>2 16.8 (1.59 – 178) 6.52 (0.50 – 84.45)
Delirium 13.78 (3.42 – 55.60) <0.001 9.33 (1.35 – 64.61) 0.024
SAPS II 1.07 (1.02 – 1.12) 0.011 1.06 (0.98 – 1.15) 0.169
a) Logistic regression analysis with enter method was used.
SAPS, Simplified Acute Physiology Score; APACHE II, Acute Physiology and Chronic Health Evaluation; RCRI, Revised Cardiac Risk Index; OR; Odds Ratio; CI,
Confidence Interval.
*Adjusted for age, length of PACU stay, erythrocytes, RCRI and SAPS II. All variables were forced into the model in logistic regression analysis.
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LOS was 10 days.Mortality
Univariate analysis identified the amount of intra-
operative erythrocytes administered, RCRI, postopera-
tive delirium, SAPS II and APACHE II as predictors for
mortality at the 6 months follow-up (Table 2).
In the multivariate analyses (Table 3) after adjustment
for univariate predictors (intra-operative erythrocytes
administered, RCRI and SAPS II) and for age and LOS
in the ICU, postoperative delirium was identified as an
independent predictor of mortality at the 6 months
follow-up.Functional capacity and ADL
Six months after discharge from the PACU, patients were
more dependent than before surgery in at least 1 I-ADL
according to the Lawton Score (32% vs 7%, p = 0.027)
(Table 4).
We found no differences in the dependency in P-ADL
and Lawton scores when comparing these variables before




Personal activities of daily living
Katz scale 0 (0–0)
Dependency in P-ADL, n (%) 2 (5)
Instrumental activities of daily living
Lawton scale 7.0 (7.0–7.0)
Dependency in I-ADL, n (%) 3 (7)
IQR, Interquartil range.
I-ADL, Instrumental Activities of Daily Living; P-ADL, Personal Activities of Daily LivinQuality of life measures
For the quality of life assessment the response rate at
the 6 months follow-up was 77% (13 patients were lost
to follow-up and did not answer the questionnaire).
Six months after hepatectomy, 45.5% of patients stated
that their health in general was better/much better on
the day of testing than 1 year earlier. However, 15.9%
considered it to be worse/much worse than 1 year previ-
ously. A total of 38.6% considered that it had remained
the same.
At the 6 months follow-up, scores for all SF-36 domains,
except for the physical function domain were similar to
the scores obtained before surgery. For this domain, the
scores observed 6 months after surgery were worse than
those recorded before surgery (Table 5).
Discussion
The principal findings of our study are as follows: (a) after
hepatectomy, the development of postoperative delirium
was considered an independent risk factor for mortality at
6 months after discharge from the PACU; (b) 6 months
after surgery, patients were more dependent with regards
to I-ADL; and (c) 6 months after hepatectomy the patients
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in this domain.
This study identified the following risk factors for mor-
tality 6 months after hepatectomy: the amount of erythro-
cytes administered intraoperatively, RCRI, postoperative
delirium and severity of disease scores.
A few studies have evaluated the effects of perioperative
transfusions in morbidity and mortality after hepatectomy
surgery. The amount of erythrocytes administered is asso-
ciated with higher blood losses, larger resections, and
increased technical difficulty [23]. In addiction, blood
transfusions have been associated with higher tumor re-
currence rates due to the immunosuppressive effects of
these transfusions [23]. In fact, hepatectomy is associated
with major perioperative blood loss. Several techniques
have been advocated in order to reduce the amount of
transfusions [24]. During inflow occlusion at the time of
parenchyma resection, the main source of bleeding is
backflow from the valveless hepatic veins and control of
central and hepatic venous pressure has been documented
as crucial to reduce the blood loss [24,25].
However, Kuroda et al. [26] recently published a retro-
spective analysis, which found that perioperative blood
transfusion did not have any influence on survival and car-
cinoma recurrence after hepatectomy surgery. Conversely,
other studies have shown that patients who received blood
transfusions had higher morbidity rates [24,27].
In this study RCRI appears as a predictor of mortality at
the 6 months follow-up. This RCRI, developed by Lee
et al. [28], has been proposed as a cardiac risk prediction
index based on clinical characteristics. However, although
this score is validated and widely used for estimating the
risk of a perioperative major adverse myocardial event
other studies have linked higher RCRI with higher mortal-
ity rates [29] [30].
APACHE II and SAPS II are two of the most commonly
used scores for prediction of outcome of patients admittedTable 5 SF-36 means before and after hepatectomy
Variable Before hepatectomy
(n = 44)
SF-36 domains mean ± sd
Physical function 85.0 ± 20.1
Role physical 58.2 ± 35.6
Bodily pain 67.5 ± 28.1
General health perception 60.3 ± 21.1
Vitality 43.4 ± 14.9
Social functioning 72.4 ± 24.5
Role emotional 68.6 ± 25.6
Mental health 52.8 ± 19.4
Wilcoxon signed rank test; SF-36, Short-form 36.to ICU: therefore, it is expected that patients with higher
scores have higher mortality rates and worse associated
outcomes; this in accordance with our results [31,32].
Delirium, or an “acute confusional state,” is a transient
global disorder of cognition. The condition is associated
with increased morbidity and mortality rates as well as
longer LOS in the hospital, ICU and post anesthesia care
units [33-41].
It is well known that mortality is associated with post-
operative delirium development in a surgical ICU. This
was documented by Leslie et al. [42] in a study that fo-
cused on delirium and outcome. Furthermore McCusker
et al. calculated hazard ratios of 2.11 for mortality in de-
lirious patients after 12 months[43]. Ely et al. [33] and
Lin et al. [44] have also reported that delirium is an in-
dependent predictor of mortality in critical care patients.
Indeed, according to their results, every day of delirium
was associated with a 10% higher risk of death and
worse long-term cognitive function [33]. However, to the
best of our knowledge, our study is the first to indicate
that delirium development is also an independent risk
factor for mortality after hepatectomy.
In our study, postoperative delirium was considered an
independent determinant for mortality at the 6 months
follow-up. This was the case not only after adjustment
for variables from the univariate analyses but also after
adjustment for potential confounders such as age and
LOS at the PACU. We have forced these variables in the
multivariate analysis because the probability of post-
operative delirium may be increased in elderly patients
and in patients who stay longer in the PACU. In fact,
age is the most consensual predictor for delirium and
this has been widely reported [45]. Postoperative delir-
ium has also been associated with longer LOS in the
ICU and PACU [46].
The outcomes assessed in this study were mortality rate,
quality of life and rate of dependency in P-ADL 6 monthsAfter hepatectomy P (a)
(n = 44)
mean ± sd
71.4 ± 30.2 0.025
63.4 ± 31.9 0.406
73.8 ± 30.6 0.326
60.5 ± 22.6 0.979
45.6 ± 14.7 0.472
65.9 ± 28.1 0.286
64.6 ± 30.7 0.463
59.1 ± 20.5 0.182
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come (i.e. 6 months after discharge from the PACU) was
chosen to minimize dropouts and to ensure that the re-
covery time was sufficient for a surgery such as hepatect-
omy. Moreover, we did not choose a period greater than 6
months in order to avoid the effects of chronic underlying
conditions or the onset of new and unrelated health pro-
blems that could interfere with our outcomes [47].
In our study, at the 6 months evaluation, 46% of the
patients stated that their general health was better/much
better than 1 year earlier, and only 16% considered their
health status it to be worse/much worse.
This shows a relatively high level of HR-QOL among
an important percentage of those who survived 6
months after discharge from the PACU and these find-
ings agree with those of other reports that used different
tools [7,48]. This is important because according to SF-
36 scores revealed that there were no differences in
quality of life before and after surgery, except in the
physical function domain.
After hepatectomy the patients enrolled in this study
had worse results for the physical function domain, but
the scores for all the other domains there were unchanged.
This may be related to a difficulty in recovering in terms
of physical activity after surgery. This drop in physical
function scores might also be a reflection of the invasive-
ness of the procedure and may also explain the number of
patients with disabilities encountered in ADL. It could also
highlight the substantial strain of therapy imposed on
patients who undergone hepatectomy.
This may also be indicative of an increased risk of
developing limitations to quality of life of patients.
Our study has several limitations. Firstly, only a small
number of patients were included in the analysis; thus,
there were only a small number of participants at the
follow-up and a limited number of mortality events. For
this small patient population, we studied multiple vari-
ables and this may have increased statistical type II
error. Even so, the sample may have been very small to
detect other statistically significant factors. Secondly, the
patients were only screened for delirium in the PACU.
This may have increased the probability of developing
delirium in patients with higher severity of disease and
more comorbidities. Furthermore, patients may have
developed delirium only after PACU discharge and de-
velopment of postoperative delirium in the later stages
may have been missed.
Thirdly, for the 6 month follow-up after PACU dis-
charge, in those instances where face-to-face conversa-
tions where not possible, patients were asked over the
telephone about their ADL performance. The possibility
of cognitive impairment, which was not evaluated at that
time, was not considered; this could also have had an
impact on their answers to the SF-36 at that time.Conclusion
In conclusion, this study shows that the development of
postoperative delirium is an independent risk factor for
mortality at the 6 month follow-up. At 6 months after
hepatectomy, survivors were more dependent in ADL
tasks and had worse scores for the physical function do-
main of the SF-36 questionnaire.
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